Chemical inhibitors of Histone cluster 2 H2AC primarily involve compounds that modulate the acetylation state of histones. Trichostatin A, Vorinostat, Panobinostat, Entinostat, Belinostat, Quisinostat, Romidepsin, Valproic Acid, Sodium Butyrate, Mocetinostat, Givinostat, and Chidamide all function as histone deacetylase (HDAC) inhibitors. These chemicals increase the acetylation levels of histones by preventing the removal of acetyl groups. Normally, HDACs maintain a balance in the histone acetylation state, which is critical for the regulation of chromatin structure and function. When HDACs are inhibited, the acetylation of Histone cluster 2 H2AC remains high, leading to a more open chromatin conformation. This alteration in chromatin structure can influence the accessibility of DNA to various cellular machinery, affecting processes that are regulated by the chromatin state, such as DNA replication and transcription.
The action of HDAC inhibitors results in an accumulation of acetylated Histone cluster 2 H2AC, making the chromatin less compact. Trichostatin A and Vorinostat are known for their broad-spectrum HDAC inhibition, altering the acetylation status of histones, including Histone cluster 2 H2AC. Panobinostat and Romidepsin, while also broad in their HDAC inhibition, are particularly potent, leading to significant increases in the acetylation levels of Histone cluster 2 H2AC. On the other hand, Entinostat and Mocetinostat offer more selective inhibition of HDAC classes, yet they still promote the accumulation of acetylated Histone cluster 2 H2AC. The increased acetylation negatively impacts the ability of histones to maintain DNA in a tightly packed structure. Sodium Butyrate and Valproic Acid, though less potent than some of the aforementioned inhibitors, still contribute to increased levels of acetylated Histone cluster 2 H2AC. Givinostat and Chidamide round out this group of HDAC inhibitors by contributing to the elevated acetylation state of histones, including Histone cluster 2 H2AC, which in turn can affect the chromatin landscape.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylase (HDAC), which can increase the acetylation of histones including Histone cluster 2 H2AC, leading to a less compact chromatin structure and potentially reducing the ability of histones to package DNA effectively. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that increases the acetylation levels of histones such as Histone cluster 2 H2AC, which can disrupt the normal chromatin compaction and histone-DNA interactions. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that can cause hyperacetylation of histones including Histone cluster 2 H2AC, potentially leading to aberrant chromatin structure and function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Selectively inhibits class I HDACs, leading to accumulation of acetylated histones including Histone cluster 2 H2AC, which can impact chromatin remodeling and function. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Inhibits HDAC enzymes, increasing the acetylation levels of histones such as Histone cluster 2 H2AC, potentially affecting their role in chromatin structure and gene regulation. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
HDAC inhibitor that can lead to hyperacetylation of histones, including Histone cluster 2 H2AC, potentially altering chromatin compaction and function. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Binds to and inhibits HDACs, leading to elevated acetylation of histones such as Histone cluster 2 H2AC, which can disrupt chromatin architecture and histone function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Increases the acetylation of histones indirectly by inhibiting HDAC, which can affect histone function including that of Histone cluster 2 H2AC by altering chromatin dynamics. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDAC inhibitor that can increase the acetylation of histones such as Histone cluster 2 H2AC, potentially disrupting chromatin structure and the ability of histones to properly organize DNA. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Inhibits HDAC, leading to increased acetylation of histones such as Histone cluster 2 H2AC, which can impact chromatin structure and the protein's capacity to maintain DNA packaging. | ||||||